Back to top

The Zacks Analyst Blog Highlights: Anthem, HCA, Dr. Reddy's and UnitedHealth

Read MoreHide Full Article

For Immediate Release

Chicago, IL –December 4, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Anthem, Inc. (ANTM - Free Report) , HCA Healthcare, Inc. (HCA - Free Report) , Dr. Reddy's Laboratories Ltd. (RDY - Free Report) and UnitedHealth Group Inc. (UNH - Free Report) .

Here are highlights from Monday’s Analyst Blog:

Healthcare Takes Wall Street Lead: 4 Picks

Wall Street recorded solid gains in the last trading session, with the S&P 500 and the Nasdaq Composite logging their best weekly performance since December 2011 and the Dow Jones Industrial Average posting the best weekly numbers since November 2016. These weekly gains helped all the three major indexes to end last month in green.

But, it was the most popular trade over the past one and a half period that has given way in November to another sector that has now taken the baton of leadership on Wall Street. The healthcare sector registered a gain of more than 6% in November, while one of the new entrants among the S&P 500’s 11 sectors, communications services turned out to be among the worst performers in the past 30 days.

And this outperformance by the health-care sector that displaced the so-called FAANG stocks — Facebook, Amazon, Apple, Netflix and Google-parent Alphabet – may not be a one-off, market pundits said.

Continuous innovation and research in the field of biotechnology and an increasingly aged population in the United States are helping whet people’s appetites for healthcare shares.

Moreover, this particular sector is more defensive in nature compared to other major S&P 500 sectors like technology. Thus, their demand has increased by leaps and bounds as U.S. economic expansion is widely expected to slow down in the coming years owing to the waning effect of the Trump administration’s corporate tax cuts.

Also, whether the stock market is a bull or bear one, the need for medical and health care products is constant. Needless to say, most of the healthcare companies are mature firms that provide stable cash flows, encouraging profits and offer some big yields. There is plenty of growth left in their tank from new drugs in development.

4 Top Picks

With that, here are four top healthcare stocks you need to scoop up today. Such stocks have a Zacks Rank #1 (Strong Buy) or 2 (Buy) and a VGM Score of A or B. Here V stands for Value, G for Growth and M for Momentum and the score is a weighted combination of these three metrics. Such a score allows you to eliminate the negative aspects of stocks and select winners.

Anthem, Inc. operates as a health benefits company in the United States. The company currently has a Zacks Rank #2 and a VGM Score of B. The Zacks Consensus Estimate for its current-year earnings moved up 1.2% in the last 60 days.  The company’s expected earnings growth rate for the current year is 30.1% compared with the Medical - HMOs industry’s expected increase of 20.2%. The stock has outperformed the broader industry in the last one-month period (+7.8% vs +6.7%).

HCA Healthcare, Inc., through its subsidiaries, provides health care services. The company currently has a Zacks Rank #2 and a VGM Score of A. The Zacks Consensus Estimate for its current-year earnings moved up 1.2% in the last 60 days.  The company’s expected earnings growth rate for the current year is 41.7% compared with the Medical - Hospital industry’s expected increase of 1.9%. The stock has outperformed the broader industry in the past month (+6.4% vs +5.6%).

Dr. Reddy's Laboratories Ltd. operates as an integrated pharmaceutical company worldwide, including the United States. The company currently has a Zacks Rank #1 and a VGM Score of A. The Zacks Consensus Estimate for its current-year earnings rose 6.8% in the last 60 days.  The company’s expected earnings growth rate for the current year is 40.6% compared with the Medical - Generic Drugs industry’s projected increase of 4.9%. The stock has outperformed the broader industry in the last one-month period (+15.1% vs -2.3%). You can see the complete list of today’s Zacks #1 Rank stocks here.

UnitedHealth Group Inc. operates as a diversified health care company in the United States. The company currently has a Zacks Rank #2 and a VGM Score of A. The Zacks Consensus Estimate for its current-year earnings moved up 0.7% in the last 60 days.  The company’s expected earnings growth rate for the current year is 27.2% compared with the Medical - HMOs industry’s expected increase of 20.2%. The stock has outperformed the broader industry in the last one-month period (+7.8% vs +6.7%).

Wall Street’s Next Amazon

Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.

Click for details >>

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com                                      

http://www.zacks.com                                                   

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.



More from Zacks Press Releases

You May Like

Published in